The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population

European Journal of Clinical Pharmacology

Volumn 62, Issue 5, 2006, Pages 355-359

  Chen, Bing ^a   Zhang, Wei Xia ^a   Cai, Wei Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chinese; Genotype; N acetyltransferase2 (NAT2); Phenotype; Polymorphism

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; N4 ACETYLSULFADIMIDINE; SULFADIMIDINE;

ADULT; ARTICLE; CHINESE; CLINICAL TRIAL; DRUG ACETYLATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NAT2 GENE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; PHENOTYPE; SULFAMETHAZINE;

EID: 33646527381     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0110-6     Document Type: Article

References (20)

1. Evans DA (1989) N-acetyltransferase. Pharmacol Ther 42:157-234
2. Rey E, Pons G, Cremier O et al (1998) Isoniazid dose adjustment in a pediatric population. Ther Drug Monit 20:50-55
3. Hiratsuka M, Kishikawa Y, Takekuma Y, et al (2002) Genotyping of the N-acetyltransferase2 polymorphism in the prediction of adverse drug reactions to isoniazid in Japanese patients. Drug Metab Pharmacokinet 17:357-362
4. Deguchi T, Mashimo M, Suzuki T (1990) Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J Biol Chem 265:12757-12760
5. Mashimo M, Suzuki T, Abe M, Duguchi T (1992) Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum Genet 90:139-143
6. Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K (1994) Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 3(5):729-734
7. Agundez JA, Olivera M, Martinez C, Ladero JM, Benitez J (1996) Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population. Pharmacogenetics 6:423-428
8. Lin HJ, Han CY, Lin BK, Hardy S (1993) Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am J Hum Genet 52:827-834
9. Xie HG, Xu ZH, OuYang DS, Shu Y, Yang DL, Wang JS, Yan XD, Huang SL, Wang W, Zhou HH (1997) Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations. Pharmacogenetics 7:503-514
10. Hein DW, Doll MA, Rustan TD, Ferguson RJ (1995) Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res 55:3531-3536
11. Kinzig-Schippers M, Tomalik-Scharte D, Jetter A, Scheidel B, Jakob V, Rodamer M, et al (2005) Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses? Antimicrob Agents Chemother. 49:1733-1738
12. Chen B, Li JH (2004) A reverse dot blot method for genotyping of NAT2 in Chinese subjects Chin Pharmacol Bull 20:1269-1272
13. Lu JF, Zhou XD, Zhu XP, Cao XM, Guo LQ, Lin SS (1997) N-acetyltransferase phenoytpe in 120 Chinese using sulfamethazine as the probe drug. Chin Pharm J 32:559-561
14. Vistisen K, Poulsen HE, Loft S (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13:1561-1568
15. Xu XM, Jiang WD (1990) Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population. Acta Pharmacologica Sinica 11:385-388
16. Smith CA, Wadelius M, Gough AC, Harrison DJ, Wolf CR, Rane A (1997) A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet 34:758-760
17. Gross M, Kruisselbrink T, Anderson K, Lang N, McGovern P, Delongchamp R, Kadlubar F (1999) Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol Biomarkers Prev 8:683-692
18. Rothman N, Hayes RB, Bi W, Caporaso N, Broly F, Woosley RL, Yin S, Feng P, You X, Meyer UA (1993) Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males. Pharmacogenetics 3:250-255
19. Zhao B, Seow A, Lee EJ, Lee HP (2000) Correlation between acetylation phenotype and genotype in Chinese women. Eur J Clin Pharmacol 56:689-692
20. Meisel P, Arndt D, Scheuch E, Klebingat KJ, Siegmund W (2001) Prediction of metabolic activity from genotype: the gene-dose effect of N-acetyltransferase. Ther Drug Monit 23:9-14